R.H. Bluestein & Co’s Evoqua Water Technologies Corp. Common Stock AQUA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$331K Hold
10,000
0.02% 219
2022
Q2
$325K Hold
10,000
0.02% 232
2022
Q1
$470K Hold
10,000
0.02% 204
2021
Q4
$468K Hold
10,000
0.02% 223
2021
Q3
$376K Hold
10,000
0.01% 268
2021
Q2
$338K Sell
10,000
-500
-5% -$15K 0.01% 301
2021
Q1
$276K Buy
10,500
+500
+5% +$13.3K 0.01% 334
2020
Q4
$270K Hold
10,000
0.01% 307
2020
Q3
$212K Hold
10,000
0.01% 319
2020
Q2
$186K Hold
10,000
0.01% 322
2020
Q1
$112K Hold
10,000
0.01% 279
2019
Q4
$190K Sell
10,000
-24,000
-71% -$430K 0.01% 333
2019
Q3
$579K Sell
34,000
-9,000
-21% -$135K 0.03% 136
2019
Q2
$612K Buy
43,000
+15,000
+54% +$195K 0.03% 126
2019
Q1
$352K Buy
+28,000
New +$333K 0.02% 186

Other funds holding AQUA

R.H. Bluestein & Co's AQUA Position: Q3 2022 in Review

R.H. Bluestein & Co held its Evoqua Water Technologies Corp. Common Stock (AQUA) position steady in Q3 2022 at 10,000 shares worth $331K. The position accounts for 0.02% of the portfolio, ranked #219.

R.H. Bluestein & Co first reported a position in AQUA in Q1 2019 and has held it in 15 quarters since. The position peaked at $612K in Q2 2019. 277 funds tracked by Wall St. Rank hold AQUA as of Q3 2022.

  • R.H. Bluestein & Co held 10,000 shares of Evoqua Water Technologies Corp. Common Stock worth $331K as of Q3 2022.
  • R.H. Bluestein & Co left its Evoqua Water Technologies Corp. Common Stock share count unchanged in Q3 2022.
  • Evoqua Water Technologies Corp. Common Stock made up 0.02% of R.H. Bluestein & Co's portfolio in Q3 2022, its #219 holding.
  • R.H. Bluestein & Co first reported a position in Evoqua Water Technologies Corp. Common Stock in Q1 2019 and has held it in 15 quarters since.
  • R.H. Bluestein & Co's Evoqua Water Technologies Corp. Common Stock position peaked at $612K in Q2 2019.
  • 277 funds tracked by Wall St. Rank held Evoqua Water Technologies Corp. Common Stock as of Q3 2022.

Based on R.H. Bluestein & Co's 13F filing for Q3 2022, filed 14 Nov 2022.